⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Celebrates its 70th Patent Award
accessnewswire.com
LEXX
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
accessnewswire.com
LEXX
Lexaria Announces Results from Animal Study GLP-1-A26-1
accessnewswire.com
LEXX
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
accessnewswire.com
LEXX
Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
AXSM
VRTX
RLMD
VSTA
PRAX
NBIX
ALTO
LLY
JNJ
MRK
ABBV
BMY
REGN
BIIB
ANVS
ALEC
LEXX
COYA
NVO
IONQ
NVDA
AMD
INTC
GOOG
MSFT
AMZN
TSLA
AAPL
META
IBM
CRM
ADBE
NFLX
CMCSA
VZ
T
KO
PEP
MCD
DIS
BA
CAT
GE
XOM
CVX
JPM
BAC
WFC
GS
MS
V
MA
HD
WMT
COST
PG
PFE
MRNA
GILD
AMGN
NVS
TAK
EXAS
CRSP
EDIT
NTLA
INCY
ALKS
ACAD
AZN
TEVA
BHC
LULU
UBER
LYFT
SPCE
PLTR
SNOW
DDOG
CRWD
ZS
PANW
FTNT
NOW
ADSK
MCHP
NXPI
ON
QCOM
MU
WDC
SE
MELI
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
NIO
XPEV
LI
RIVN
LCID
PLUG
FCEL
BE
SPWR
ENPH
SEDG
RUN
NEO
CLSK
CRBU
RXRX
DTIL
ADPT
CYTK
IMUX
MNKD
SRPT
BNTX
RVMD
ACRS
EXEL
FGEN
GNTX
HRMY
INSM
ITRM
KODK
LPCN
NCLH
OCGN
ORGO
PACB
PBYI
PEGA
PLRX
PRGS
PTON
PYPL
QGEN
QRVO
RDNT
REPL
ROKU
RYAAY
SAVA
SBAC
SCLX
SDRL
SEIC
SIRI
SMCI
SNPS
SOFI
SPOT
SSYS
STX
SWKS
SYK
TCOM
TEAM
TER
TGT
TMO
TMUS
TXN
UAL
ULTA
UPS
VRSK
WDAY
XEL
XYL
ZBRA
Lexaria Updates Financial Position
accessnewswire.com
LEXX
Chronic Pain Market Poised for Growth Through 2036 as Rising Prevalence and Innovative Therapies Drive New Opportunities
globenewswire.com
ABBV
LLY
AMGN
TEVA
TONX
PFE
VRTX
AXSM
LEXX
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
accessnewswire.com
LEXX
Form 8-K
sec.gov
LEXX
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
accessnewswire.com
LEXX
LEXXW